2 results
Approved WMOCompleted
OBJECTIVES:To evaluate the effect of TRC101 on the progression of chronic kidney disease and to evaluate the safety profile of TRC101 in CKD patients with metabolic acidosis.
Approved WMOPending
- Primary: Determine safety and feasibility of immuno-OCT in vivo imaging with the tracer Bevacizumab-800CW. - Secondary: Validate the immuno-OCT endoscopy system based on:o Fluorescence molecular endoscopy;o Ex vivo fluorescence imaging; o Ex vivo…